GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kopran Ltd (NSE:KOPRAN) » Definitions » Price-to-Funds-From-Operations

Kopran (NSE:KOPRAN) Price-to-Funds-From-Operations : (As of Dec. 12, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Kopran Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Kopran Business Description

Industry
Traded in Other Exchanges
Address
Dr. E. Moses Road, 1076, Parijat House, Worli, Mumbai, MH, IND, 400 018
Kopran Ltd is an Indian based pharmaceutical company. It is engaged in manufacturing of Formulation (Finished Dosage Form) and Active Pharmaceutical Ingredients (API) i.e., Pharmaceuticals. It manufactures dosage forms including, tablets, capsules, dry powder, suspension, and injectables. Some of its product range includes antibiotics, cardiovascular, anti-diabetes, respiratory, pain management, and gastrointestinal. Geographically, it has a presence in India; South Africa; Ethiopia; Zambia; Egypt; Jordan and Rest of World.